These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 1495947)

  • 1. CEA immunoreactivity in metastatic malignant melanoma.
    Selby WL; Nance KV; Park HK
    Mod Pathol; 1992 Jul; 5(4):415-9. PubMed ID: 1495947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of CEA-related positivity in primary and metastatic malignant melanoma.
    Sanders DS; Evans AT; Allen CA; Bryant FJ; Johnson GD; Hopkins J; Stocks SC; Marsden JR; Kerr MA
    J Pathol; 1994 Apr; 172(4):343-8. PubMed ID: 8207615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining for Ki-67 antigen, carcinoembryonic antigen, and p53 in the differential diagnosis of glandular lesions of the cervix.
    Cina SJ; Richardson MS; Austin RM; Kurman RJ
    Mod Pathol; 1997 Mar; 10(3):176-80. PubMed ID: 9071723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CEA reactivity in amelanotic malignant melanoma of the anal canal.
    Ben-Izhak O; Lichtig C
    Pathol Res Pract; 1993 Nov; 189(9):1071-6; discussion 1077-83. PubMed ID: 8302727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical evaluation of nonspecific cross reactive antigen and carcinoembryonic antigen (CEA) in urinary bladder carcinoma.
    Asamoto M; Fukushima S; Tatemoto Y; Yamada K; Yuba R; Mori M
    Anticancer Res; 1989; 9(2):319-26. PubMed ID: 2751258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody recognizing human melanoma-carcinoma cross-reacting oncofetal antigen epitopically associated with carcinoembryonic antigen.
    Liao SK; Kwong PC; Clarke BJ; Dent PB; Ryan ED; Khosravi MJ; Laferte S; Krantz MJ
    J Natl Cancer Inst; 1985 May; 74(5):1047-58. PubMed ID: 2582173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMB-45 detection in adenocarcinomas.
    Hancock C; Allen BC; Herrera GA
    Arch Pathol Lab Med; 1991 Sep; 115(9):886-90. PubMed ID: 1718237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMB-45 and Melan-A are useful in the differential diagnosis between granular cell tumor and malignant melanoma.
    Gleason BC; Nascimento AF
    Am J Dermatopathol; 2007 Feb; 29(1):22-7. PubMed ID: 17284958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemical evaluation of human esophageal neoplasms and preneoplastic lesions for beta-chorionic gonadotropin, placental lactogen, alpha-fetoprotein, carcinoembryonic antigen, and nonspecific cross-reacting antigen.
    Burg-Kurland CL; Purnell DM; Combs JW; Hillman EA; Harris CC; Trump BF
    Cancer Res; 1986 Jun; 46(6):2936-43. PubMed ID: 2421889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical distinction of classic and chondroid chordomas.
    Walker WP; Landas SK; Bromley CM; Sturm MT
    Mod Pathol; 1991 Sep; 4(5):661-6. PubMed ID: 1722044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical differentiation of malignant mesothelioma, mesothelial hyperplasia and metastatic adenocarcinoma in serous effusions, utilizing staining for carcinoembryonic antigen, keratin and vimentin.
    Duggan MA; Masters CB; Alexander F
    Acta Cytol; 1987; 31(6):807-14. PubMed ID: 2447718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma-associated antigen recognized by T cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma with fine-needle aspiration.
    Fetsch PA; Marincola FM; Filie A; Hijazi YM; Kleiner DE; Abati A
    Cancer; 1999 Feb; 87(1):37-42. PubMed ID: 10096358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial and melanoma antigens in gliosarcoma. An immunohistochemical study.
    Gottschalk J; Jautzke G; Schreiner C
    Pathol Res Pract; 1992 Feb; 188(1-2):182-90. PubMed ID: 1594490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical characterization of ovarian borderline tumors of intestinal and mullerian types.
    Rutgers JL; Bell DA
    Mod Pathol; 1992 Jul; 5(4):367-71. PubMed ID: 1495942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoembryonic antigen from human malignant melanoma cells. II. Grafting of the cells in the hamster cheek pouch.
    Hakim AA
    Ann Immunol (Paris); 1983; 134D(3):333-47. PubMed ID: 6687105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clear cell sarcoma. An immunohistochemical analysis of six cases and comparison with other epithelioid neoplasms of soft tissue.
    Swanson PE; Wick MR
    Arch Pathol Lab Med; 1989 Jan; 113(1):55-60. PubMed ID: 2521288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correspondence re: W. Lawrence Selby, Keith V. Nance, and H. Kim Park, CEA immunoreactivity in metastatic malignant melanoma. Mod. Pathol 5:415, 1992.
    Murphy JK
    Mod Pathol; 1993 May; 6(3):392. PubMed ID: 8346188
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.